2020 BRN Discussion, page-24816

Quarterly review due soon. As discussed previously, it's unlikely we'll see any sales revenue for a quarter or two - so what might we expect?

1. We have around 20 EAP customers worth $50-200k, according to Lou's last podcast.
2. I'd expect all of them to have signed and paid their initial entry fee to EAP, with some paying for at least some support component prior to end December 2020.
3. If we used the base of $50k as the sign-ons fee then quarterly should show $1m (enough to give the finger to soldiers, pigs and other ignored posters who keep raising revenue). We could easily see, say, $2m if the EAP isn't a flat $50k for everyone or if some have paid for some support. I wouldn't really expect a lot more than that, or say $2.5m, for the EAP customers.
4. Renesas is the big question. Lou says they are 'material', but I wouldn't expect sales revenue yet for a couple of quarters. The big question is whether Renesas paid a licensing fee that will be brought to book before 31 December. Did the parties sign and hand/receive a payment or did they sign and send an invoice (and if so is the invoice accrued to the December quarter books)?
5. My conclusion is that anything over a couple of million in revenue in the quarterly will give us a pretty decent starting idea of an IP licencing fee for a major global company.
6. I'm excited.
7. I've had a look through some Renesas reports but having trouble finding how many chips they produce as a starter for possible sales revenue. May have to go with revenue and assumptions on proportion of Renesas revenue that may use Akida and the percentage to BRN.

Just my musings. DYOR.